Skip to main content
Clinical Trials/NCT06851156
NCT06851156RecruitingNot Applicable

An Exploratory Trial Evaluating Temporal Interference Stimulation of CM-pf In Patients With Disorders of Consciousness

Xijing Hospital2 sites in 1 country10 target enrollmentStarted: April 7, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
10
Locations
2
Primary Endpoint
CRS-R total score changes

Study Overview

Brief Summary

The purpose of this academic lead study is to explore the effect of noninvasive neuromodulation of the CM-pf via tTIS for patients with disorders of consciousness.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • traumatic and nontraumatic etiology of VS/UWS or MCS according to published diagnostic criteria.

Exclusion Criteria

  • patients in coma, with less than 1 week after acute brain insult, with fluctuating diagnosis on baseline assessment, and with a metallic cerebral implant or pacemaker, and with epilepsy.

Outcomes

Primary Outcomes

CRS-R total score changes

Time Frame: From enrollment to the end of treatment at 10 days

Coma Recovery Scale-Revised scale score, with score ranging from 0 to 23, was used to evaluate the consciousness condition.

Secondary Outcomes

  • Numbers of patients with improved consciousness(From enrollment to the end of treatment at 10 days)
  • EEG changes(From enrollment to the end of treatment at 10 days)

Investigators

Sponsor
Xijing Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Transcranial Temporal Interference... | Clinical Trial